Aflibercept for ROP Shows Sustained Efficacy at Age 3 ...Middle East

Medscape - News
Myopia was less common and less severe in patients who received aflibercept than in patients who received laser photocoagulation, a study shows. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Aflibercept for ROP Shows Sustained Efficacy at Age 3 )

Apple Storegoogle play

Also on site :